Roche
ROG.SW
#28
Rank
A$542.40 B
Marketcap
A$681.75
Share price
0.97%
Change (1 day)
34.54%
Change (1 year)

Roche (ROG.SW) - Cash on Hand

Cash on Hand as of December 2025 : A$27.54 Billion

According to Roche's latest financial reports the company has A$27.54 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Roche - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$29.18 B-5.32%
2024-12-31A$30.82 B67.99%
2023-12-31A$18.34 B18.1%
2022-12-31A$15.53 B-21.02%
2021-12-31A$19.67 B8.12%
2020-12-31A$18.19 B4.06%
2019-12-31A$17.48 B-7.64%
2018-12-31A$18.93 B19.96%
2017-12-31A$15.78 B27.25%
2016-12-31A$12.40 B-2.67%
2015-12-31A$12.74 B-11.92%
2014-12-31A$14.46 B-4.08%
2013-12-31A$15.08 B2.23%
2012-12-31A$14.75 B25.72%
2011-12-31A$11.73 B2.18%
2010-12-31A$11.48 B-42.48%
2009-12-31A$19.96 B-29.27%
2008-12-31A$28.22 B15.44%
2007-12-31A$24.45 B-3.61%
2006-12-31A$25.37 B16.95%
2005-12-31A$21.69 B47.28%
2004-12-31A$14.72 B-15.89%
2003-12-31A$17.51 B-52.09%
2002-12-31A$36.54 B-41.6%
2001-12-31A$62.58 B30.25%
2000-12-31A$48.05 B28.63%
1999-12-31A$37.35 B9.47%
1998-12-31A$34.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$28.32 B 2.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$16.24 B-41.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$21.11 B-23.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$10.89 B-60.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.30 B-51.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$14.72 B-46.53%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
A$0.91 B-96.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$25.66 B-6.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$6.26 B-77.26%๐Ÿ‡ฌ๐Ÿ‡ง UK